Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events (Docetaxel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01110291
Recruitment Status : Completed
First Posted : April 26, 2010
Last Update Posted : April 27, 2010
Sponsor:
Collaborators:
Sanofi
Turku University Hospital
Vaasa Central Hospital, Vaasa, Finland
medbase Oy Ltd
Information provided by:
University of Turku

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2004
Actual Study Completion Date : March 2009